Sep 11, 2023 / 02:00PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Okay. Go ahead and get started. Welcome, everyone. This will be a fireside chat with BioMarin. My name is Vikram Purohit. I'm one of the biotech analysts with the research team. Happy to have with me the CFO of BioMarin, Brian Mueller, with us. Thanks so much for joining us, Brian.
Before we get into the session, I just need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/research disclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So with that, let's get started. Brian, we'd just love to open it to you for some opening remarks on the business and some key highlights you think that BioMarin's achieved throughout the year and then we'll go from there.
Brian R. Mueller - BioMarin Pharmaceutical Inc. - CFO & Executive VP
Yes. Thanks. Appreciate it
Biomarin Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers